COc1ccc(NC(=O)/C(CC2=Nc3ccc([N+](=O)[O-])cc3NC2O)=N\NC(=O)C[N+](C)(C)C)c(OC)c1.[Cl-]
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?